MRI-Guided TULSA Effective at Five Years for Localized Prostate Cancer

MONDAY, March 25, 2024 -- For the treatment of localized prostate cancer, in-bore, magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) results in favorable outcomes at five years, including durable oncologic control and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news